Lipocine Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Salt Lake City, United States
SEC filing record 1 source field available
Fiscal year end
31 December
Lipocine Inc. has filed 806 SEC EDGAR filings since 30 Nov 2011

SEC filing history

Showing 226-250 of 806 matching filings.

Per page
25
Current page
10
4

4 filing

Filing date
12 Apr 2022
Reporting date
11 Apr 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
12 Apr 2022
Reporting date
11 Apr 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
12 Apr 2022
Reporting date
11 Apr 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
12 Apr 2022
Reporting date
11 Apr 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
PRE 14A File 001-36357

PRE 14A filing

Filing date
12 Apr 2022
Reporting date
12 Apr 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K File 001-36357

10-K filing

Filing date
09 Mar 2022
Reporting date
31 Dec 2021
Next action
Verify source filing
8-K/A File 001-36357

8-K/A filing

Filing date
07 Mar 2022
Reporting date
07 Mar 2022
Next action
Verify source filing
SC 13G/A File 005-87564

SCHEDULE 13G/A

Filing date
10 Feb 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
27 Jan 2022
Reporting date
19 Jan 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
03 Jan 2022
Reporting date
03 Jan 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
08 Dec 2021
Reporting date
07 Dec 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
08 Dec 2021
Reporting date
07 Dec 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
18 Nov 2021
Reporting date
18 Nov 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .